Treatment OutcomeNauseaAntineoplastic AgentsDrug Administration ScheduleDouble-Blind MethodDose-Response Relationship, DrugPilot ProjectsNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsDrug-Related Side Effects and Adverse ReactionsAntipsychotic AgentsDrug Therapy, CombinationAnalgesics, OpioidClinical Trials as TopicAdministration, OralTime FactorsVomitingDrug EvaluationPainAdministration, TopicalAnalgesicsProspective StudiesPain, PostoperativeBasal Ganglia DiseasesPain MeasurementAnti-Inflammatory Agents, Non-SteroidalDelayed-Action PreparationsDrug EruptionsAnticonvulsantsFollow-Up StudiesDrug Delivery SystemsMorphinePlacebosAnti-Inflammatory AgentsImmunosuppressive AgentsModels, MolecularClozapineHaloperidolGlucocorticoidsPatient CompliancePhytotherapyRetrospective StudiesInjections, SpinalHypertrichosisDrug CombinationsBenzodiazepinesRecombinant ProteinsDermatologic AgentsAkathisia, Drug-InducedInjections, IntravenousAnalgesiaPruritusRandom AllocationFentanylDrug InteractionsGastrointestinal DiseasesQuality of LifeMolecular Sequence DataInfusions, IntravenousRisperidoneAnesthetics, LocalDyskinesia, Drug-InducedOintmentsPolyethylene GlycolsInjections, IntramuscularAnalgesia, EpiduralAnalgesia, Patient-ControlledAntiviral AgentsAlopeciaPrednisoloneDisease Models, AnimalCombined Modality TherapyAmino Acid SequenceSchizophreniaRandomized Controlled Trials as TopicDrug ToleranceRats, Sprague-DawleyHeadacheBupivacaineAntidepressive Agents, TricyclicCyclohexanecarboxylic AcidsCyclosporineRecurrenceDrug CarriersDrug Evaluation, PreclinicalStructure-Activity RelationshipProtein ConformationAntidepressive AgentsInjectionsAdministration, CutaneousBinding SitesInterferon-alphaAdrenal Cortex HormonesPatient Satisfaction